Literature DB >> 12642668

The role of disulfide bonds in the assembly and function of MD-2.

Gregory E D Mullen1, Margaret N Kennedy, Alberto Visintin, Alessandra Mazzoni, Cynthia A Leifer, David R Davies, David M Segal.   

Abstract

MD-2 is a secreted glycoprotein that binds to the extracellular domain of Toll-like receptor 4 (TLR4) and is required for the activation of TLR4 by lipopolysaccharide (LPS). The protein contains seven Cys residues and consists of a heterogeneous collection of disulfide-linked oligomers. To investigate the role of sulfhydryls in MD-2 structure and function, we created 17 single and multiple Cys substitution mutants. All of the MD-2 mutant proteins, including one totally lacking Cys residues, were secreted and stable. SDSPAGE analyses indicated that most Cys residues could participate in oligomer formation and that no single Cys residue was required for oligomerization. Of the single Cys substitutions, only C95S and C105S failed to confer LPS responsiveness on TLR4 when mutant and TLR4 were cotransfected into cells expressing an NF-kappaB reporter plasmid. Surprisingly, substitution of both C95 and C105 partially restored activity. Structural analyses revealed that C95 and C105 formed an intrachain disulfide bond, whereas C95 by itself produced an inactive dimer. In contrast to the cotransfection experiments, only WT MD-2 conferred responsiveness to LPS when secreted proteins were added directly to TLR4 reporter cells. Our data are consistent with a model in which most, possibly all sulfhydryls lie on the surface of a stable MD-2 core structure where they form both intra- and interchain disulfide bridges. These disulfide bonds produce a heterogeneous array of oligomers, including some species that can form an active complex with TLR4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642668      PMCID: PMC153023          DOI: 10.1073/pnas.0630495100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness.

Authors:  Fabio Re; Jack L Strominger
Journal:  J Biol Chem       Date:  2002-04-25       Impact factor: 5.157

Review 2.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

3.  Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition.

Authors:  S Akashi; Y Nagai; H Ogata; M Oikawa; K Fukase; S Kusumoto; K Kawasaki; M Nishijima; S Hayashi; M Kimoto; K Miyake
Journal:  Int Immunol       Date:  2001-12       Impact factor: 4.823

4.  Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4.

Authors:  A Visintin; A Mazzoni; J A Spitzer; D M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

Review 5.  Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes.

Authors:  R Dziarski; D Gupta
Journal:  J Endotoxin Res       Date:  2000

6.  MD-2 binds to bacterial lipopolysaccharide.

Authors:  S Viriyakosol; P S Tobias; R L Kitchens; T N Kirkland
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

7.  N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide.

Authors:  T Ohnishi; M Muroi; K Tanamoto
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

8.  Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein.

Authors:  Mateja Mancek; Primoz Pristovsek; Roman Jerala
Journal:  Biochem Biophys Res Commun       Date:  2002-04-12       Impact factor: 3.575

9.  MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor.

Authors:  Jean da Silva Correia; Richard J Ulevitch
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

10.  MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A.

Authors:  Masashi Muroi; Takahiro Ohnishi; Ken-ichi Tanamoto
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  21 in total

1.  Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling.

Authors:  Pearl Gray; Kathrin S Michelsen; Cherilyn M Sirois; Emily Lowe; Kenichi Shimada; Timothy R Crother; Shuang Chen; Constantinos Brikos; Yonca Bulut; Eicke Latz; David Underhill; Moshe Arditi
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

2.  The dsRNA binding site of human Toll-like receptor 3.

Authors:  Jessica K Bell; Janine Askins; Pamela R Hall; David R Davies; David M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-23       Impact factor: 11.205

3.  Radioiodination of an endotoxin·MD-2 complex generates a novel sensitive, high-affinity ligand for TLR4.

Authors:  Athmane Teghanemt; Jerrold P Weiss; Theresa L Gioannini
Journal:  Innate Immun       Date:  2013-02-25       Impact factor: 2.680

4.  Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.

Authors:  So Young Kim; Jung Eun Koo; Yun Jee Seo; Nisha Tyagi; Eunshil Jeong; Jaeyoung Choi; Kyung-Min Lim; Zee-Yong Park; Joo Young Lee
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

5.  Dimerization of Toll-like receptor 3 (TLR3) is required for ligand binding.

Authors:  Yan Wang; Lin Liu; David R Davies; David M Segal
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

6.  Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

Authors:  Christopher W Cluff; Jory R Baldridge; Axel G Stöver; Jay T Evans; David A Johnson; Michael J Lacy; Valerie G Clawson; Vonnie M Yorgensen; Craig L Johnson; Mark T Livesay; Robert M Hershberg; David H Persing
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 7.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

8.  Signatures of positive selection in LY96 gene in vertebrates.

Authors:  Tonghai Dou; Maobin Fu; Yixia Wang; Yang Zhao; Zhengshi Wang; Zhengqian Bian; Yan Zhou
Journal:  J Biosci       Date:  2013-12       Impact factor: 1.826

9.  Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations.

Authors:  Theresa L Gioannini; Athmane Teghanemt; DeSheng Zhang; Nathan P Coussens; Wendie Dockstader; S Ramaswamy; Jerrold P Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

10.  Free thiol group of MD-2 as the target for inhibition of the lipopolysaccharide-induced cell activation.

Authors:  Mateja Mancek-Keber; Helena Gradisar; Melania Iñigo Pestaña; Guillermo Martinez de Tejada; Roman Jerala
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.